TherapeuticsMD (TXMD) Change in Cash (2010 - 2026)

TherapeuticsMD has reported Change in Cash for 17 years, with the latest figure at $936000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 36.44% year-over-year to $936000.0; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (up 90.05% YoY), and the FY2025 full-year result was $2.4 million, up 231.15% from the prior year.
• Change in Cash for Q1 2026 stood at $936000.0, up from $368000.0 in the prior quarter.
• The five-year high for Change in Cash was $12.0 million in Q3 2022, with the low at -$34.7 million in Q1 2022.
• Historically, Change in Cash has averaged -$3.3 million across 5 years, with a median of $12000.0 in 2024.
• Annual changes were most pronounced in 2022 — Change in Cash plunged 160.8% — and 2025, when it jumped 6136.36%.
• TherapeuticsMD's Change in Cash stood at $11.0 million in 2022, then plunged by 153.14% to -$5.8 million in 2023, then soared by 100.21% to $12000.0 in 2024, then soared by 2966.67% to $368000.0 in 2025, then surged by 154.35% to $936000.0 in 2026.
• The last three Change in Cash figures came in at $936000.0 (Q1 2026), $368000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.